Abstract
The design and development of drug delivery vectors are complex, multi-step processes that require extensive efforts for chemical characterization, mass production, toxicity testing, and preclinical and clinical trials. When using conventional batch-type discontinuous reactors in their fabrication, the scarce control on mixing conditions required to produce drug loaded particles, especially as the reactor volume is increased, leads to polydisperse distributions and batch-to-batch variations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
